Stock data

睿生光電 (6861)

睿生光電 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$299.88M, up 57.1% from a year earlier. EPS over the last four quarters totals NT$6.48.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 睿生光電 in Insightr